Variant report
Variant | nsv877241 |
---|---|
Chromosome Location | chr3:103090241-103151043 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZPLD1-8 | chr3:103142393-103142559 | l_2420_NR_026934 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7653853 | chr3:103090241-103090242 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs386664047 | chr3:103090251-103090252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7639969 | chr3:103090262-103090263 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs146704326 | chr3:103090263-103090264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370438493 | chr3:103090326-103090327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139361320 | chr3:103090394-103090395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563536737 | chr3:103090457-103090458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530614445 | chr3:103090507-103090508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545719498 | chr3:103090522-103090523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141807853 | chr3:103090544-103090545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532384888 | chr3:103090590-103090591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114834057 | chr3:103090613-103090614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553496357 | chr3:103090658-103090659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559603522 | chr3:103090667-103090668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552548905 | chr3:103090699-103090700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187320315 | chr3:103090722-103090723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568469226 | chr3:103090734-103090735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548392181 | chr3:103090741-103090742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530289497 | chr3:103090767-103090768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9878942 | chr3:103090774-103090775 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs542971941 | chr3:103090826-103090827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192212958 | chr3:103090881-103090882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563075914 | chr3:103090898-103090899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552921802 | chr3:103090918-103090919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181875242 | chr3:103090927-103090928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534606833 | chr3:103090929-103090930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552889865 | chr3:103090932-103090933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528352090 | chr3:103090944-103090945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116555066 | chr3:103090962-103090963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75418607 | chr3:103090976-103090977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545509427 | chr3:103090979-103090980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556757311 | chr3:103090987-103090988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575129057 | chr3:103090996-103090997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150482467 | chr3:103091003-103091004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs73849676 | chr3:103091004-103091005 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs374490324 | chr3:103091006-103091007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572761093 | chr3:103091009-103091010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79266589 | chr3:103091059-103091060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78760510 | chr3:103091071-103091072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs527790979 | chr3:103091082-103091083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559746333 | chr3:103091092-103091093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs138412147 | chr3:103091108-103091109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148366330 | chr3:103091128-103091129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548700348 | chr3:103091151-103091152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529015421 | chr3:103091193-103091194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185845064 | chr3:103091205-103091206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531152961 | chr3:103091236-103091237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552760352 | chr3:103091237-103091238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149240628 | chr3:103091242-103091243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376257629 | chr3:103091258-103091259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:103088800-103091000 | Enhancers | Fetal Brain Male | brain |
2 | chr3:103089800-103091400 | Enhancers | Fetal Brain Female | brain |
3 | chr3:103104800-103105400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr3:103105000-103105600 | Enhancers | Fetal Brain Male | brain |
5 | chr3:103106400-103107400 | Enhancers | Colon Smooth Muscle | Colon |
6 | chr3:103106800-103107600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr3:103106800-103107800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr3:103107000-103107400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr3:103107000-103107600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr3:103107000-103107600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr3:103107200-103107400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr3:103107400-103107600 | Enhancers | Fetal Brain Male | brain |
13 | chr3:103107800-103112200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr3:103112200-103113200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr3:103112600-103113200 | Enhancers | NH-A | brain |
16 | chr3:103121200-103122400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr3:103121800-103122600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr3:103128800-103129200 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |